A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

Beyond Air (NASDAQ:XAIR) said on Thursday that the United States Patent and Trademark Office (USPTO) has issued a U.S. Patent ...

Symptoms that persist long after Lyme disease is treated are not uncommon—a 2022 study found that 14% of patients who were ...

At least two cases of listeria have been linked to ice cream in the Baltimore metro area, prompting health and safety ...

A new antibiotic called gepotidacin may soon offer a better way to treat gonorrhea, especially as traditional treatments ...

Researchers at the University of Oxford have developed a new drug delivery system using ultrasound-activated nanoparticles to ...

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...

The type of antibiotic will depend on the bacteria present and the severity of the symptoms. Without treatment, the infection usually disappears in 14 to 21 days. With treatment, symptoms should ...

PHAXIAM Therapeutics (Euronext: PHXM - FR001400K4B1), a biopharmaceutical company ("the Company" or "PHAXIAM") developing innovative treatments for severe and resistant bacterial infections, announces ...

DOCTORS are prescribing antibiotics for tens of thousands of patients with infections, with little or no consideration of ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...